Columnist Candace Semien plunges into the debate of whether to use disabled, differently abled, or another term to describe a ...

Among the many things columnist Candace Semien had to learn while living with lupus were the types and function of various ...

The U.S. Food and Drug Administration has granted regenerative medicine advanced therapy (RMAT) designation to Fate's FT819 for lupus.

The FDA has granted fast track status to ADI-001, Adicet Bio’s CAR T-cell therapy for treatment-resistant systemic lupus erythematosus (SLE).

Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and other organs.

The FDA granted fast track designation to SC291 as a potential treatment for hard-to-manage systemic lupus erythematosus (SLE).

Columnist Marisa Zeppieri has learned that taking a rest with lupus can be necessary and shouldn't cause guilt.

Columnist Marisa Zeppieri shares insight she gained, before she got married, about chronic illness and dating.

A recent beach adventure prompts columnist Candace Semien to reflect on the value of doing something for the first time.

Stopping glucocorticoid therapy after achieving remission did not increase the risk of symptom flare-ups in SLE patients, data showed.

About 91% of lupus patients report they are using or had been using oral steroids to manage their symptoms, according to a global survey.

Ampel BioSolutions is launching LuGENE, a lupus blood test that uses AI to look at gene activity to predict flares and personalize treatments.